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CASE REPORTS
Patient 1 was born in the United
States to consanguineous Pakistani
parents. He was well until 8 months of
age when he developed fever, hep-
atosplenomegaly, pneumonia, and ane-
mia. A diagnosis of disseminated MAC
infection was made. Subsequently,
he was found to have complete absence
of IFN-γ responsiveness caused by
a homozygous mutation in the IFN-γ
receptor 1 gene6 (Table). At age 3
years, he developed disseminated cy-
tomegalovirus infection with pneumo-
nia, diagnosed by positive cultures of
blood and bronchoalveolar lavage
fluid, as well as visualization of typical
cytomegalic inclusion cells in the latter;
he required mechanical ventilation and
prolonged therapy with ganciclovir,
administered intravenously. Two
months later, he developed parain-
fluenza virus type 3 pneumonia, diag-
nosed by culture of bronchoalveolar
lavage fluid, which was complicated by
respiratory failure requiring mechani-
cal ventilation. Five months later he
Humans with absent or diminished re-
sponse to interferon-γ caused by non-
functional or dysfunctional IFN-γ re-
ceptors have recently been described.1-8
These patients acquire mycobacterial
infections that are frequently due to low
virulence species such as Mycobacterium
avium complex and are often dissemi-
nated and refractory to treatment. In-
fections with Salmonella species and
other intracellular bacteria also occur in
patients with IFN-γ receptor deficien-
cy.1,5,7 However, increased susceptibili-
ty to viral infections has not been rec-
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ognized previously. We have identified
4 patients with IFN-γ receptor dysfunc-
tion and symptomatic viral infections
with either DNA or RNA viruses. This
recently recognized aspect of human
IFN-γ receptor deficiency broadens the
phenotype for consideration of this
newly described primary immunodefi-
ciency disease.
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CMV Cytomegalovirus
HSV Herpes simplex virus
IFN-γ Interferon-γ
MAC Mycobacterium avium complex
RSV Respiratory syncytial virus
VZV Varicella zoster virus
Interferon-γ receptor deficiency is a recently described immunodeficiency
that is associated with onset of severe mycobacterial infections in childhood.
We describe the occurrence of symptomatic and often severe viral infections
in 4 patients with interferon-γ receptor deficiency and mycobacterial dis-
ease. The viral pathogens included herpes viruses, parainfluenza virus type
3, and respiratory syncytial virus. We conclude that patients with interfer-
on-γ receptor deficiency and mycobacterial disease have increased suscepti-
bility to some viral pathogens. (J Pediatr 1999;135:640-3)
See editorial, p. 543.
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had severe respiratory syncytial virus
pneumonia, diagnosed by culture of
bronchoalveolar lavage fluid, for
which mechanical ventilation was
again required. This infection was
treated with aerosolized ribavirin and
intravenous RSV immune globulin
(RespiGam; Medimmune, Gaithers-
burg, Md). On 2 subsequent occasions
he developed pneumonia with respira-
tory failure requiring mechanical ven-
tilation, although no specific causative
agents were identified.
Patient 2 was born in the United
States to parents of English and Por-
tuguese descent who were not known
to be consanguineous. He was well as
an infant, but at age 2 years he devel-
oped fever, lymphadenopathy, and he-
patosplenomegaly caused by dissemi-
nated M fortuitum and MAC
infections.3 He had no detectable IFN-γ
responsiveness because of a homozy-
gous mutation in IFN-γ receptor 2. At
age 3 he developed oral ulcers, vesicu-
lar skin lesions, and severe retrosternal
pain associated with eating, which re-
sulted in weight loss. Herpes simplex
virus was isolated from an oral lesion.
Within 3 days of beginning oral acy-
clovir therapy (60 mg/kg/d), his ap-
petite improved, and he was back to
normal within 1 week. Acyclovir ther-
apy was continued for 3 weeks. Ap-
proximately 5 weeks later, he had a re-
currence of oral lesions similar in
appearance to those of the prior
episode, not associated with retroster-
nal pain. He was treated with acy-
clovir, administered orally, without
further recurrence of lesions.
Patient 3 had complete absence of
IFN-γ receptor function because of
compound heterozygous mutations in
the IFN-γ receptor 1.7 She was vacci-
nated with bacille Calmette-Guérin as
an infant and first came to medical at-
tention at age 4 months with fever,
pneumonia, axillary lymphadenopathy,
hepatomegaly, and a vesicular skin
rash. At first, appearance of the rash
was typical of varicella infection, but
new vesicles formed for at least 10
days, and the rash took on the appear-
ance of Kaposi’s varicelliform eruption.
Serologic testing revealed presence of
varicella-specific IgM antibody; cul-
ture was not performed. The rash re-
solved with acyclovir treatment. Cul-
tures from a lymph node biopsy
specimen obtained at that time grew
bacille Calmette-Guérin; biopsies of
lung and liver were not performed.
Subsequent infections included dis-
seminated MAC, disseminated M
kansasii, and Listeria monocytogenes
meningitis.
Patient 4 was born to nonconsan-
guineous parents of Korean and
African descent. He was well until age
6 years when he developed multifocal
osteomyelitis caused by M kansasii, and
since then he has had recurrent dis-
seminated infections with numerous
nontuberculous mycobacteria. Genetic
analysis showed heterozygosity for a
mutant IFN-γ receptor allele containing
a single nucleotide insertion (817insA),
which codes for a protein with domi-
nant negative function.8 At age 17
years he developed shortness of
breath, with numerous vesicular skin,
pharyngeal, and lingual lesions. Patchy
infiltrates were seen on chest x-ray
film, and mechanical ventilation was
required for progressive respiratory
failure. Electron microscopy per-
formed on scrapings from skin lesions
showed viral particles consistent with
a herpes group virus, and serology
confirmed a diagnosis of acute varicel-
la. He was treated with intravenous
acyclovir and gradually improved.
DISCUSSION
IFN-γ is a pleiotropic cytokine pro-
duced by activated T lymphocytes and
natural killer cells. It acts via its cog-
nate receptor to directly stimulate an-
timicrobial activities of monocytes/
macrophages, and it plays a major role
in activation of cell-mediated immuni-
ty. IFN-γ was first recognized for its in
vitro antiviral activity.9 Its importance
in the in vivo immune response has
since been confirmed in mice with tar-
geted disruptions of the IFN-γ or IFN-γ
receptor genes. These knockout mice
have increased susceptibility to a wide
spectrum of infectious agents, includ-
ing mycobacteria,10-13 bacteria,14-16
parasites,17-20 and viruses. After exper-
imental inoculation, infections with the
DNA viruses HSV,21,22 murine
CMV,23 murine gammaherpesvirus,24
and vaccinia virus25 are more pro-
longed and/or severe in these knockout
mice than in normal mice. Single-
strand RNA viruses pathogenic in
these mouse models include Theiler’s
virus,26 lymphocytic choriomeningitis
virus,25,27 and mouse hepatitis virus (a
coronavirus).28
Patients with nonfunctional or dys-
functional IFN-γ receptors clearly
have increased susceptibility to my-
cobacterial infections. These infections
tend to be severe and difficult to treat
and have been the major recognized
cause of morbidity and mortality in
this patient group. Salmonella and Lis-
teria monocytogenes infections have also
been described in a subset of patients
with IFN-γ receptor deficiency and
mycobacterial infections.1,5,7 However,
increased susceptibility to viral infec-
tions in patients with IFN-γ receptor
deficiency has not been previously rec-
ognized. In each of the patients in this
report, viral infection was symptom-
atic, and infection was severe in sever-
al instances. All patients had herpes
virus infections, paralleling the height-
ened susceptibility of IFN-γ and IFN-
γ receptor knockout mice to herpes
viruses.21-24 Patient 1 also had severe
infections with parainfluenza virus
type 3 and RSV, both of which are sin-
gle-stranded RNA viruses.
Our clinical experience differs from
that reported previously by others. Six-
teen French children with idiopathic
disseminated bacille Calmette-Guérin
infection, identified in a national retro-
spective survey, were reported to have
had normal clinical courses and fre-
quency of infections with common
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childhood pathogens, including varicel-
la.29 However, genetic and immunolog-
ic defects in those patients were not
known and are likely to be heteroge-
neous, making comparison with the pa-
tients in this report difficult. In a small
group of patients with IFN-γ receptor
deficiency, Jouanguy et al30 reported
normal recovery from infections caused
by rotavirus, rhinovirus, influenza
virus, RSV, and varicella zoster virus
and positive serologies for HSV, Ep-
stein-Barr virus, and CMV without his-
tories of clinical disease. Explanations
for this apparent discrepancy include
the possibilities that: (1) some patients
with IFN-γ receptor dysfunction may
have additional genetic factors that af-
fect their susceptibility to viral infec-
tions; (2) viral disease may be favored
by concomitant mycobacterial infection
and poor clinical status; and (3) as
more children with IFN-γ receptor mu-
tations are identified, a broader spec-
trum of infection susceptibility may be-
come apparent.
Although disseminated infection
with non tuberculous mycobacteria is
the most common clinical presentation
of IFN-γ receptor deficiency in the pa-
tients described to date, our experience
suggests that the frequency and severi-
ty of viral infections may also be in-
creased in patients with this primary
immunodeficiency. IFN-γ receptor de-
ficiency should be included in the dif-
ferential diagnosis in children with se-
vere viral infections. In patients known
to have IFN-γ receptor deficiency,
viral pathogens should be considered
in appropriate clinical settings.
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